MedTrace Logo

Taste Properties of HIV Inhibitor

NCT02608918 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2018-04-17

No results posted yet for this study

Summary

The purpose of the study is to assess the taste properties of HIV inhibitor

Conditions

  • HIV Infections

Interventions

DRUG

BMS-955176

Sponsors & Collaborators

  • Senopsys, LLC

    collaborator INDUSTRY

  • ViiV Healthcare

    lead INDUSTRY

Principal Investigators

  • Viiv Clinical Trials · ViiV Healthcare

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-05
Primary Completion
2016-05-24
Completion
2016-05-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02608918 on ClinicalTrials.gov